Skip to main content Help with accessibility Skip to main navigation

BISPHOSPHONATES, intravenous for treating osteoporosis

Last Updated: 27 September 2017

Body System: Endocrine System


The Pan Mersey Area Prescribing Committee recommends the prescribing of INTRAVENOUS BISPHOSPHONATES (ibandronic acid and zoledronic acid), by specialists only, for treating osteoporosis in accordance with NICE TA464.